Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Dec 2024 for Jasper Therapeutics, Inc., €6,082. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Jeetinder Singh Mahal: trading record in brief
This profile gathers the share dealings of Jeetinder Singh Mahal in Jasper Therapeutics, Inc. We count 8 filings; the first trade dates from 12 October 2022 and the latest from 12 December 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 12 December 2024 with an option exercise (€6,082) in Jasper Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeetinder Singh Mahal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
900 shares@ US$7.105.6% of flowVoting Common StockSEC:0001213900-24-108551:0
900 shares@ US$7.105.3% of flowVoting Common StockSEC:0001213900-24-078214:0
900 shares@ US$7.105.4% of flowVoting Common StockSEC:0001213900-24-052215:0
900 shares@ US$7.105.4% of flowVoting Common StockSEC:0001213900-24-021961:0
37,126 shares@ US$0.8527.5% of flowVoting Common StockSEC:0001013762-23-003903:0
9,000 shares@ US$0.715.4% of flowVoting Common StockSEC:0001213900-23-048683:0
37,126 shares@ US$1.4645.3% of flowVoting Common StockSEC:0001213900-23-029893:0
214,722 shares0Voting Common StockSEC:0001213900-22-063941:0
8 of 8 declarations
